Bhavnagri Veer
Related Filers (1)
Other (2)
144
Thursday, 6/29/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 6/20/2023
Filing for proposed sale of securities under Rule 144
Ownership (21)
4
Thursday, 3/16/2023
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/14/2023
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/18/2023
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/19/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/25/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/17/2022
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/17/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/17/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/16/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/16/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/17/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/16/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/30/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/17/2021
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/18/2020
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/8/2020
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/2/2020
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/3/2020
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/5/2020
Allogene Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 4/22/2020
Allogene Therapeutics, Inc.: Initial statement of beneficial ownership of securities